Business ❯ Market Trends

Pharmaceutical Market

Drug Pricing Generic Drugs Regulated Markets Strategic Focus Weight Loss Drugs Drug Sales Weight Loss Industry Weight Loss Drug Market Patient Demand Telehealth Growth Obesity Treatment Incretin Market Growth Projections Drug Development Sales Growth

Lilly Sues Six U.S. Firms Over Black‑Market Sales of Experimental Drug Retatrutide

Lilly says the lawsuits are intended to force platforms and regulators to cut off an unsafe black‑market supply chain for its unapproved drug.

Oral GLP‑1s Reshape Obesity Market as Approvals, Policy Talks and M&A Accelerate Growth

Lilly’s Foundayo Start Trails Wegovy as Street Stays Positive

Eli Lilly’s GLP-1 Lead Faces New Pressure From Novo’s Weight-Loss Pill

Eli Lilly Shifts to Access-First Strategy on GLP-1 Strength

Pfizer Licenses Early-Stage Oral GLP-1 From YaoPharma in Up to $2 Billion Deal

Sanofi to Acquire Blueprint Medicines for $9.1 Billion, Boosting Its Rare Immunology Pipeline